Rapid resolution of acute and transient psychotic disorder with the homoeopathic medicine: A case report
Journal of Integrated Standardized Homoeopathy · 2025
DOI: 10.25259/jish_10_2024 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Integrated Standardized Homoeopathy, 2025. Verfasst von Vivek G. Vasoya und 1 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Acute and transient psychotic disorder includes highly variable symptoms including delusions, hallucinations and disorganised thinking without warning, reaching peak severity within 2 weeks. Episodes most often resolve within days to a month. Unrelated to other medical conditions, substance use or withdrawal, this disorder presents a unique challenge in terms of management. In the present case, Kali Bromatum, a homoeopathic medicine, was effectively used for treatment. The patient showed significant improvement from initial severity scores to complete recovery, as measured using two tools: The Clinician-Rated Dimensions of Psychosis Symptom Severity and Modified Naranjo Criteria. This approach contrasts with traditional methods that may require antipsychotics or hospitalisation, illustrating the potential of homoeopathy in managing such disorders within a home setting.
Zitieren
APA
Vasoya, V. G., & Umaretiya, N. J. (2025). Rapid resolution of acute and transient psychotic disorder with the homoeopathic medicine: A case report. Journal of Integrated Standardized Homoeopathy. https://doi.org/10.25259/jish_10_2024
Vancouver
Vasoya VG, Umaretiya NJ. Rapid resolution of acute and transient psychotic disorder with the homoeopathic medicine: A case report. Journal of Integrated Standardized Homoeopathy. 2025. doi:10.25259/jish_10_2024
BibTeX
@article{Vasoya2025,
author = {Vasoya, Vivek G. and Umaretiya, Nimisha J.},
title = {Rapid resolution of acute and transient psychotic disorder with the homoeopathic medicine: A case report},
journal = {Journal of Integrated Standardized Homoeopathy},
year = {2025},
doi = {10.25259/jish_10_2024}
}
EUVIMED